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Introduction
•

Serotonin Syndrome is a severe drug reaction
stemming from an increase in serotonergic activity
in the nervous system at the 5HT-1A & 5HT-2A
receptors associated with the use of several
medications.

•

Symptoms are variable, and include altered
mental status and autonomic and neuromuscular
hyperactivity.

•

Treatment consists of withdrawal of causative
agents and supportive care along with
benzodiazepines, with the possible addition of
cyproheptadine for more severe cases.

•

We present a case of Serotonin Syndrome
caused by the interaction of Metoclopramide and
Sertraline
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Figure 1. Clinical Presentations, adapted from Francescangeli
et al (2019).

Conclusion

Case Description
• HPI: A 34 year old Female with a past medical
history of anxiety on sertraline who presented for
evaluation of altered mental status. The patient
was seen at an urgent care the previous evening
complaining of headache and insomnia, and was
discharged home after receiving lorazepam,
diphenhydramine, and metoclopramide. A few
hours later, the patient was brought to the
Emergency Department becoming increasingly
confused and agitated, with reported auditory and
visual hallucinations.
• PE: The patient was afebrile and
hemodynamically stable, but appeared restless,
diaphoretic, and would not follow commands.
Mydriasis and choreiform movements of the upper
and lower extremities were noted, and reflexes
were found to be 2+ in the upper extremities and
3+ in lower extremities without any clonus.

• Given the patient’s long term SSRI use,
suspicion for Serotonin Syndrome was
raised based on the Hunter Criteria.
• The patient was treated with IV Diazepam
and supportive care, and symptoms resolved
over the following 24 hours without the use of
cyproheptadine.
rd
• The patient was discharged home on the 3
hospital day, with instructions to avoid
metoclopramide in the future while on an
SSRI.

Table 1. Hunter Serotonin Toxicity Criteria, adapted from
Dunkley et al (2003)

• This case exemplifies the importance of
understanding drug interactions as well
as counseling patients on adverse
effects of medications.
• Additionally, this case raises awareness
to the rare but well-studied
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